GlassScriptPhysician profile
Lenay Santana
NPI 1124215538
$2,157.56
in general payments reported to CMS, 2019-2025
23 companies · $476 in 2025
The $476 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $481 · 2020: $173 · 2021: $121 · 2022: $270 · 2023: $267 · 2024: $369 · 2025: $476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,111.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $543.79 | 2019-2025 | Ultomiris |
| Argenx US, INC. | $365.34 | 2023-2024 | Vyvgart, Vyvgart Hytrulo |
| Amgen INC. | $201.26 | 2019-2021 | |
| Ucb, INC. | $146.67 | 2019-2024 | Zilbrysq |
| Neurelis, INC. | $121.36 | 2025 | Valtoco |
| Eisai INC. | $121.24 | 2025 | |
| Biogen, INC. | $113.00 | 2025 | Vumerity |
| Novartis Pharmaceuticals Corporation | $94.56 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $78.45 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $58.04 | 2019-2021 | |
| Lilly USA, LLC | $43.80 | 2019-2020 | |
| Ge Healthcare | $43.36 | 2019 | |
| Genzyme Corporation | $33.38 | 2019 | |
| Abbvie INC. | $29.75 | 2021-2022 | |
| Acadia Pharmaceuticals INC | $26.86 | 2019-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $26.48 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $17.62 | 2021 | |
| Tanabe Pharma America, INC. | $17.19 | 2019 | |
| Emd Serono, INC. | $17.04 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.69 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $15.26 | 2020 | |
| Mdd US Operations, LLC | $13.95 | 2021 | |
| Jazz Pharmaceuticals INC. | $12.47 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lenay Santana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.